Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of montelukast on airway remodeling biomarkers in children with intermittent asthma
2008-006373-33Phase 3Active
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of montelukast in intermittent asthma and asthma, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Primary endpoint: change in TIMP-1 levels. Started Dec 2008; status: active.
02
Drugs
montelukast
03
Conditions
intermittent asthmaasthma
Beyond the preview
Go deeper on 2008-006373-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006373-33.